selumetinib 7.5 MG Oral Granules

RxCUI: 2723659
RxNorm name: selumetinib 7.5 MG Oral Granules
Display name: selumetinib 7.5 MG Oral Granules
Full name: selumetinib 7.5 MG Oral Granules
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
KOSELUGO	SELUMETINIB	AstraZeneca Pharmaceuticals LP	7d042c61-f28f-4ab5-ab10-d7558c0d49ff	2026-05-26	Warnings, Adverse reactions	Exact identifier rxcui: 2723659

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
7d042c61-f28f-4ab5-ab10-d7558c0d49ff	selumetinib 7.5 MG Oral Granules	PSN	17	These highlights do not include all the information needed to use KOSELUGO safely and effectively. See full prescribing information for KOSELUGO. KOSELUGO ® (selumetinib) capsules, for oral use KOSELUGO ® (selumetinib) oral granules Initial U.S. Approval: 2020	20260526
7d042c61-f28f-4ab5-ab10-d7558c0d49ff	selumetinib 7.5 MG Oral Granules	SCD	17	These highlights do not include all the information needed to use KOSELUGO safely and effectively. See full prescribing information for KOSELUGO. KOSELUGO ® (selumetinib) capsules, for oral use KOSELUGO ® (selumetinib) oral granules Initial U.S. Approval: 2020	20260526